Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,889
archived clinical trials in
Blood Cancer

Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Medical Center of Akron
mi
from
Akron, OH
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Medical Center of Akron
mi
from
Akron, OH
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Dayton Children's Hospital
mi
from
Dayton, OH
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Dayton Children's Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Toledo Children's Hospital
mi
from
Toledo, OH
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Toledo Children's Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Natalie Warren Bryant Cancer Center at Saint Francis
mi
from
Tulsa, OK
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Natalie Warren Bryant Cancer Center at Saint Francis
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Legacy Emanuel Hospital and Health Center
mi
from
Portland, OR
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Legacy Emanuel Hospital and Health Center
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Palmetto Health Richland
mi
from
Columbia, SC
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Palmetto Health Richland
mi
from
Columbia, SC
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
BI-LO Charities Children's Cancer Center
mi
from
Greenville, SC
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
BI-LO Charities Children's Cancer Center
mi
from
Greenville, SC
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Sanford USD Medical Center - Sioux Falls
mi
from
Sioux Falls, SD
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Sanford USD Medical Center - Sioux Falls
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
T C Thompson Children's Hospital
mi
from
Chattanooga, TN
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
T C Thompson Children's Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Texas Tech University Health Sciences Center at Amarillo
mi
from
Amarillo, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Texas Tech University Health Sciences Center at Amarillo
mi
from
Amarillo, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Cook Children's Medical Center
mi
from
Fort Worth, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Covenant Children's Hospital
mi
from
Lubbock, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Covenant Children's Hospital
mi
from
Lubbock, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of San Antonio
mi
from
San Antonio, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Primary Children's Hospital
mi
from
Salt Lake City, UT
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
University of Vermont College of Medicine
mi
from
Burlington, VT
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
University of Vermont College of Medicine
mi
from
Burlington, VT
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Carilion Clinic Children's Hospital
mi
from
Roanoke, VA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Carilion Clinic Children's Hospital
mi
from
Roanoke, VA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Mary Bridge Children's Hospital and Health Center
mi
from
Tacoma, WA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Mary Bridge Children's Hospital and Health Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Madigan Army Medical Center
mi
from
Tacoma, WA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
West Virginia University Charleston Division
mi
from
Charleston, WV
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
West Virginia University Charleston Division
mi
from
Charleston, WV
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Monash Medical Center-Clayton Campus
mi
from
Clayton,
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Monash Medical Center-Clayton Campus
mi
from
Clayton,
Click here to add this to my saved trials
A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Central Connecticut
mi
from
Southington, CT
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Central Connecticut
mi
from
Southington, CT
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Cancer & Blood Disease Center
mi
from
Lecanto, FL
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Cancer & Blood Disease Center
mi
from
Lecanto, FL
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
UCSD Moores Cancer Center
mi
from
La Jolla, CA
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
UCSD Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Desert Hematology Oncology Medical Group, Inc
mi
from
Rancho Mirage, CA
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Desert Hematology Oncology Medical Group, Inc
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Northwestern University Medical Center Division of Hematology/Oncology
mi
from
Chicago, IL
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Northwestern University Medical Center Division of Hematology/Oncology
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Indiana University Cancer Center
mi
from
Indianapolis, IN
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Karmanos Cancer Institute
mi
from
Detroit, MI
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Long Island Jewish Medical Center CLL Research and Treatment Program
mi
from
New Hyde Park, NY
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Phase 2, Multi-Center, Randomized, Double-Blinded, Parallel Group Study of the Safety and Efficacy of Different Lenalidomide (REVLIMID®) Dose Regimens in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Long Island Jewish Medical Center CLL Research and Treatment Program
mi
from
New Hyde Park, NY
Click here to add this to my saved trials